A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture. [electronic resource]
Producer: 20171226Description: 1276-1290 p. digitalISSN:- 1879-114X
- Aged
- Antibodies, Monoclonal -- economics
- Bone Density Conservation Agents -- economics
- Cost-Benefit Analysis
- Denosumab -- economics
- Female
- Humans
- Models, Theoretical
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- economics
- Parathyroid Hormone-Related Protein -- economics
- Postmenopause
- Quality-Adjusted Life Years
- Risk
- Teriparatide -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.